[Stress ulcer prophylaxis in the intensive care unit].
de Bel
E E
EE
van der Spoel
J I
JI
D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003422:Critical Care / Q000379:methods*; D003428:Cross Infection / Q000453:epidemiology; D004750:Enteral Nutrition; D006801:Humans; D015994:Incidence; D007362:Intensive Care Units / Q000639:trends; D009426:Netherlands / Q000453:epidemiology; D010438:Peptic Ulcer Hemorrhage / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D011899:Ranitidine / Q000627:therapeutic use; D013392:Sucralfate / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D013392:Sucralfate; D011899:Ranitidine